These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27490973)

  • 1. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.
    Carbone F; Satta N; Montecucco F; Virzi J; Burger F; Roth A; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Lalive PH; Mach F; Fainardi E; Vuilleumier N
    Eur J Clin Invest; 2016 Sep; 46(9):805-17. PubMed ID: 27490973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes.
    Mannic T; Satta N; Pagano S; Python M; Virzi J; Montecucco F; Frias MA; James RW; Maturana AD; Rossier MF; Vuilleumier N
    Endocrinology; 2015 Dec; 156(12):4707-19. PubMed ID: 26393305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
    Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
    Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
    J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.
    Satta N; Pagano S; Montecucco F; Gencer B; ; Mach F; Kaiser L; Calmy A; Vuilleumier N
    J Infect; 2018 Feb; 76(2):186-195. PubMed ID: 29198606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin/adiponectin ratio predicts poststroke neurological outcome.
    Carbone F; Burger F; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Bertolotto M; Dallegri F; Mach F; Fainardi E; Montecucco F
    Eur J Clin Invest; 2015 Nov; 45(11):1184-91. PubMed ID: 26381386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
    Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
    Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
    Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
    Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
    Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
    Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
    Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
    Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Bastardot F; Hartley O; Montecucco F; Mach F; Waeber G; Vollenweider P; Vuilleumier N
    Thromb Haemost; 2016 Sep; 116(4):764-71. PubMed ID: 27384400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up.
    Liberale L; Montecucco F; Bonaventura A; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Fainardi E; Carbone F
    Eur J Clin Invest; 2017 Oct; 47(10):702-710. PubMed ID: 28783210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
    Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
    Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
    Wick PA; Mombelli A; Pagano S; Moren X; Giannopoulou C; Mach F; Roux-Lombard P; Vuilleumier N
    J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke.
    Carbone F; Vuilleumier N; Burger F; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Mach F; Fainardi E; Montecucco F
    Eur J Clin Invest; 2015 Jun; 45(6):579-86. PubMed ID: 25845543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.
    Liberale L; Montecucco F; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Mach F; Fainardi E; Carbone F
    Eur J Clin Invest; 2016 Dec; 46(12):1053-1062. PubMed ID: 27759884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals.
    Lagerstedt JO; Dalla-Riva J; Marinkovic G; Del Giudice R; Engelbertsen D; Burlin J; Petrlova J; Lindahl M; Bernfur K; Melander O; Nilsson J; Schiopu A
    J Intern Med; 2019 Jan; 285(1):49-58. PubMed ID: 30028049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.